These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7929867)

  • 1. Digoxin disposition in elderly humans with hypochlorhydria.
    Hui J; Geraets DR; Chandrasekaran A; Wang YM; Caldwell JH; Robertson LW; Donnerberg RL; Reuning RH
    J Clin Pharmacol; 1994 Jul; 34(7):734-41. PubMed ID: 7929867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of tablet and capsule formulations of digoxin in the elderly.
    Hui J; Wang YM; Chandrasekaran A; Geraets DR; Caldwell JH; Robertson LW; Reuning RH
    Pharmacotherapy; 1994; 14(5):607-12. PubMed ID: 7997395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of [20R]-dihydrodigoxin from digoxin in humans.
    Reuning RH; Shepard TA; Morrison BE; Bockbrader HN
    Drug Metab Dispos; 1985; 13(1):51-7. PubMed ID: 2858377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of digoxin and main metabolites/derivatives in healthy humans.
    Hinderling PH; Hartmann D
    Ther Drug Monit; 1991 Sep; 13(5):381-401. PubMed ID: 1957331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic technique.
    Shepard TA; Hui J; Chandrasekaran A; Sams RA; Reuning RH; Robertson LW; Caldwell JH; Donnerberg RL
    J Chromatogr; 1986 Jul; 380(1):89-98. PubMed ID: 3745397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of digoxin and its metabolites in urine after a single oral dose in healthy subjects.
    Magnusson JO; Bergdahl B; Bogentoft C; Jonsson UE; Tekenbergs L
    Biopharm Drug Dispos; 1982; 3(3):211-8. PubMed ID: 7139062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.
    Robertson LW; Chandrasekaran A; Reuning RH; Hui J; Rawal BD
    Appl Environ Microbiol; 1986 Jun; 51(6):1300-3. PubMed ID: 3729400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of gastric acidity on the bioavailability of digoxin.
    Cohen AF; Kroon R; Schoemaker R; Hoogkamer H; van Vliet A
    Ann Intern Med; 1991 Oct; 115(7):540-5. PubMed ID: 1883123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(5):481-5. PubMed ID: 1606994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin and metabolites in urine: a derivatization--high-performance liquid chromatographic method capable of quantitating individual epimers of dihydrodigoxin.
    Bockbrader HN; Reuning RH
    J Chromatogr; 1984 Sep; 310(1):85-95. PubMed ID: 6501524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin metabolism in patients.
    Peters U; Falk LC; Kalman SM
    Arch Intern Med; 1978 Jul; 138(7):1074-6. PubMed ID: 666466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D; Teien A; Bjerkelund CJ
    Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects.
    Saltzman JR; Kowdley KV; Pedrosa MC; Sepe T; Golner B; Perrone G; Russell RM
    Gastroenterology; 1994 Mar; 106(3):615-23. PubMed ID: 8119531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].
    Ochs H; Bodem G; Kodrat G; Savic B; Baur MP
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2430-4. PubMed ID: 810339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gastric pH on digoxin biotransformation. II. Extractable urinary metabolites.
    Gault H; Kalra J; Ahmed M; Kepkay D; Longerich L; Barrowman J
    Clin Pharmacol Ther; 1981 Feb; 29(2):181-90. PubMed ID: 7460482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of digoxin and absorption site.
    Magnusson JO; Bergdahl B; Bogentoft C; Jonsson UE
    Br J Clin Pharmacol; 1982 Aug; 14(2):284-5. PubMed ID: 7104181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
    Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
    J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of tritiated digoxin and metabolites in urine by liquid chromatography.
    Eriksson BM; Tekenbergs L; Magnusson JO; Molin L
    J Chromatogr; 1981 May; 223(2):401-8. PubMed ID: 7251795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein-mediated intestinal and biliary digoxin transport in humans.
    Drescher S; Glaeser H; Mürdter T; Hitzl M; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2003 Mar; 73(3):223-31. PubMed ID: 12621387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.